Adaptive Biotechnologies Corp. · 2 months ago
Senior Director, National Payer Accounts
United States
Full-time
Remote
Director/Executive
$230K/yr - $344K/yr
14+ years expAdaptive Biotechnologies is a company focused on transforming disease diagnosis and treatment through the adaptive immune system. They are seeking a Senior Director, National Payer Accounts to develop and execute strategies for expanding patient access to their diagnostic tests by building relationships with national and regional payers and influencing payer decision-making.
BiotechnologyHealth CareTherapeutics
No H1B
Responsibilities
Set the payer strategy and vision for identified national and regional payer accounts; lead medical policy, coverage, and contracting approaches to expand access to clonoSEQ and future diagnostic tests developed by Adaptive
Own the contract lifecycle with identified national and regional payers: negotiate, close, implement, and drive pull through-with clear operational handoffs and KPIs
Integrate Adaptive solutions into payer value based care programs and clinical pathways; design pilots with payers and scale proven models across geographies and lines of business
Build and deepen multilevel payer relationships (medical policy, contracting, clinical programs, HTAs/LBMs) and with organizations that influence payer decisions
Develop account strategies for assigned payer targets; coach and direct the team to maximize coverage, pricing, and utilization outcomes
Create contracting plans and forecasts; perform rate/volume/ROI modeling that reflects regulatory requirements and reimbursement risk scenarios
Lead cross functional initiatives with Medical Affairs, Value & Access, Reimbursement Operations, Legal & Compliance, Sales and Strategic Accounts, Marketing, Regulatory/Quality, Data Analytics, and Account Operations
Serve as executive point of contact for complex negotiations, aligning multiple decision makers and senior leadership to accelerate time to close
Provide voice of payer insights to internal teams on policy trends, contract performance, denials drivers, and service levels; initiate corrective actions and content updates
Partner with Field Sales/Strategic Accounts to align regional plans, deliver reimbursement training, identify KoL advocates for payer policy support, and enable adoption within assigned integrated healthcare systems
Plan and host payer engagements (executive briefings, lab/site visits, advisory sessions); represent Adaptive at industry meetings, trade shows, and scientific forums
Monitor industry, regulatory, scientific, and competitive developments and incorporate learnings into strategy, pricing, and external positioning
Resolve payer account issues, mobilizing internal experts to remove barriers to coverage, pricing, and adjudication; escalate systemic issues with action plans
Cultivate strategic external relationships (payer trade associations, professional societies, disease management organizations, employer/broker channels) to shape policy and pathway adoption
Track and report performance (policy wins, contracts executed, covered lives, ASP/denial trends, cycle times) and adjust tactics based on results
All other duties as assigned
Qualification
Required
Bachelors in a scientific or business discipline + 17 years of related experience, or
Masters + 14 years of related experience, or
PhD + 10 years of related experience
15+ years in the healthcare or laboratory industry, with deep expertise in market access, payer strategy, or managed care
5+ years of people management experience, including leading teams and developing talent
Proven record of securing coverage policies and executing contracts with national and regional payers, including successful pull‑through
Demonstrated experience with innovative molecular diagnostics, specialty oncology therapeutics (medical benefit), and/or medical device markets
Established, influential relationships with key payer decision‑makers and industry stakeholders
Consistent achievement of or exceeding defined goals; success in complex payer negotiations (e.g., disruptive innovation adoption, reversing contract terminations, improving rates, contracting for previously excluded services)
Ability to lead and work effectively across Medical Affairs, HEOR, Legal, Reimbursement, and Commercial teams in a fast‑paced, matrixed environment
Strong project management, financial analysis, and communication skills; consultative selling expertise and relevant technical training
Preferred
Relevant advanced degrees and/or healthcare certifications
Experience and a proven track record with personalized medicine products or services
Experience with government payers, ACO contracting, coverage policy, oncology specialty pharmacy, employer group contracting, health system contracting, health economics
Benefits
Equity grant
Bonus eligible
Company
Adaptive Biotechnologies Corp.
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$531.85MKey Investors
OrbiMedARK Investment ManagementMatrix Capital Management
2022-09-12Post Ipo Debt· $125M
2022-03-24Post Ipo Equity
2020-07-14Post Ipo Equity
Leadership Team
Chad Robins
CEO & Co-Founder
Harlan Robins
co-founder and chief Scientific Officer
Recent News
Company data provided by crunchbase